We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IONS Ionis Pharmaceuticals Inc

2.16 (4.37%)
Dec 02 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,740,451
Bid Price 39.65
Ask Price 52.00
News -
Day High 51.8899


52 Week Range


Day Low 48.73
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
2.16 4.37% 51.63 00:00:12
Open Price Low Price High Price Close Price Prev Close
49.32 48.73 51.8899 51.63 49.47
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19,283 1,740,451 $ 50.55 $ 87,984,534 - 32.69 - 51.8899
Last Trade Time Type Quantity Stock Price Currency
18:46:47 1 $ 51.80 USD

Ionis Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.41B 143.47M - 587.37M -269.72M -1.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ionis Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IONS Message Board. Create One! See More Posts on IONS Message Board See More Message Board Posts

Historical IONS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week49.5351.889948.0549.29835,3812.104.24%
1 Month44.3551.889943.9648.321,035,8617.2816.41%
3 Months40.6451.889940.3946.041,114,51510.9927.04%
6 Months41.3251.889938.2643.261,113,87810.3124.95%
1 Year40.6651.889932.6940.611,057,10510.9726.98%
3 Years50.5564.3725.0440.291,129,8561.082.14%
5 Years58.8588.707525.0447.671,075,918-7.22-12.27%

Ionis Pharmaceuticals Description

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |